EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES
Clinical trials for EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES explained in plain language.
Never miss a new study
Get alerted when new EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES trials appear
Sign up with your email to follow new studies for EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill combo offers hope for kids with relapsed cancers
Disease control Recruiting nowThis study tests two oral drugs, eflornithine (DFMO) and AMXT 1501, in children and young adults up to age 26 with certain cancers that have come back or not responded to treatment. The cancers include neuroblastoma, brain tumors, and sarcomas. The goal is to find a safe dose and…
Matched conditions: EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES
Phase: PHASE1, PHASE2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Jul 01, 2026 23:00 UTC
-
New hope for kids with rare brain cancer: trial combines chemo and radiation
Disease control Recruiting nowThis study tests a combination of chemotherapy and focused radiation in children newly diagnosed with a rare brain tumor called ETMR. About 70 children will receive standard treatments to see if this approach helps keep the tumor from growing for at least 6 months. The goal is to…
Matched conditions: EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Tailor-Made T-Cells take on childhood brain cancer
Disease control Recruiting nowThis early-stage trial tests whether personalized immune cells (T-cells) can safely treat young children with aggressive brain tumors. The T-cells are designed to attack unique markers found on each child's tumor. Up to 12 children under 5 with embryonal brain tumors or recurrent…
Matched conditions: EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES
Phase: PHASE1 • Sponsor: Children's National Research Institute • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for toddlers with aggressive brain cancer: experimental spinal-fluid chemo
Disease control Recruiting nowThis early-phase study tests whether adding chemotherapy directly into the spinal fluid (intrathecal topotecan) followed by maintenance pills is feasible for children under 6 with high-risk embryonal brain tumors. About 15 children will receive this treatment after standard high-…
Matched conditions: EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES
Phase: EARLY_PHASE1 • Sponsor: C17 Council • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Rare brain tumor registry launches to unlock secrets of ETMR
Knowledge-focused Recruiting nowThis study creates a worldwide registry for children diagnosed with Embryonal Tumor with Multilayer Rosettes (ETMR), a rare and aggressive brain tumor. Researchers will collect medical records, tumor tissue, and treatment outcomes from up to 100 patients of any age. The goal is t…
Matched conditions: EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES
Sponsor: Hackensack Meridian Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC